Simbec-Orion

Simbec-Orion Volunteer for a clinical trial: Transform lives, advance science, be a medical trailblazer

Our clinical pharmacology unit was established in 1976 and is part of Simbec-Orion. With over 45 years of operation, we are one of Europe’s leading clinical research organisations providing clinical research services to both the European and international pharmaceutical industry. We are part of the MHRA Phase I Accreditation Scheme and have carried out over 1800 clinical trials. Our purpose-built UK 58-bed clinical unit is staffed and led by a team of experienced physicians/doctors, research nurses, physiologists, technicians who provide cover 24 hours a day, seven days a week. Our full range of equipment and on-site facilities are designed to give volunteers and patients an informed and comfortable experience from screening through to trial completion.

Rheumatoid Arthritis is what's known as an auto-immune condition. This means that the immune system, which is the body’s...
12/11/2025

Rheumatoid Arthritis is what's known as an auto-immune condition. This means that the immune system, which is the body’s natural self-defence system, gets confused and starts to attack your body’s healthy tissues. In rheumatoid arthritis, the main way it does this is with inflammation in your joints (Arthritis UK)

If you have RA, you may be eligible to participate in a clinical study at Simbec-Orion investigating a new potential treatment. Click the following link to learn more:

researchuk.co.uk/trial/clinical-study-rheumatoid-arthritis

A huge thank you to the 70 volunteers who attended for screening appointments last month! You are amazing ✨
09/11/2025

A huge thank you to the 70 volunteers who attended for screening appointments last month!

You are amazing ✨

Did you know?💡🌍In 2019, 18 million people worldwide were living with rheumatoid arthritis (1).About 70% of people living...
07/11/2025

Did you know?💡

🌍In 2019, 18 million people worldwide were living with rheumatoid arthritis (1).
About 70% of people living with rheumatoid arthritis are women, and 55% are older than 55 years
👫13 million people with rheumatoid arthritis experience severity levels (moderate or severe) that could benefit from rehabilitation
👏While rheumatoid arthritis is a systemic autoimmune disease that affects multiple body systems, the joints of hands, wrists, feet, ankles, knees, shoulders and elbows are most often affected

Trial 36676 is investigating a treatment for rheumatoid arthritis, click the link below to learn more and apply today ✨

https://researchuk.co.uk/trial/clinical-study-rheumatoid-arthritis



(Source: https://www.who.int/news-room/fact-sheets/detail/rheumatoid-arthritis)

✨ New Trial Alert ✨We will soon be conducting a trial for healthy females aged 18-55, who use one of the following metho...
05/11/2025

✨ New Trial Alert ✨

We will soon be conducting a trial for healthy females aged 18-55, who use one of the following methods of contraception:

🚺Non-hormonal intrauterine device (IUD)
🚺Bilateral tubal ligation (performed at least 3 months prior to screening)
🚺Vasectomised partner (sterilization performed at least 90 days prior to Screening with the appropriate post-vasectomy documentation)

If you are potentially interested in this trial, join our volunteer database today and become one of the first to receive the full details and screening availability upon release (limited slots will be available) 🥳
https://researchuk.co.uk/take-part-today

If you participate in trial 36676 you will receive an inconvenience of £2050, in addition to a £100 screening fee and £7...
04/11/2025

If you participate in trial 36676 you will receive an inconvenience of £2050, in addition to a £100 screening fee and £75 travel expenses for each journey required.

To learn more, click the link below:
www.researchuk.co.uk/trial/clinical-study-36676

Trial 36646 is recruiting volunteers with a BMI between 28-40kg/m² to participate in a study exploring how a WVE-007 is ...
24/10/2025

Trial 36646 is recruiting volunteers with a BMI between 28-40kg/m² to participate in a study exploring how a WVE-007 is processed by and acts within the body. Whilst WVE-007 has demonstrated potential to support weight loss, the focus of this study is to learn how the body absorbs and responds to the drug. If you wish to learn more or submit an application, click the link below:

https://researchuk.co.uk/trial/clinical-study-36446

Trial 36676 is investigating study drug P2-101, used in the treatment of allergic reactions. This trial compares the act...
22/10/2025

Trial 36676 is investigating study drug P2-101, used in the treatment of allergic reactions. This trial compares the active ingredient adrenaline in the form of a tablet dissolved under the tongue in comparison with the very common injectable form, such as EpiPen®. The trial involves two treatment periods, each containing one overnight stay. If you participate in this trial you will receive an inconvenience payment following study completion of £2050, in addition to a £100 screening fee and £75 travel expenses for each journey required.

To learn more, click the link below:
www.researchuk.co.uk/trial/clinical-study-36676

You can also follow us on Instagram to see more 🥳
21/10/2025

You can also follow us on Instagram to see more 🥳

For each volunteer you refer who participates in a trial, you can receive £100 ✨
19/10/2025

For each volunteer you refer who participates in a trial, you can receive £100 ✨

Address

Unit 21, Merthyr Tydfil Industrial Park
Merthyr Tydfil
CF484DR

Opening Hours

Monday 8am - 5pm
Tuesday 8am - 5pm
Wednesday 8am - 5pm
Thursday 8am - 5pm
Friday 8am - 5pm

Website

Alerts

Be the first to know and let us send you an email when Simbec-Orion posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Simbec-Orion:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram